Menjón-Beltrán, SOlivencia-Dueso, RGonzález-Jiménez, ETitos, MJ2012-10-102012-10-102007-06-19Menjón-Beltrán S, Olivencia-Dueso R, González-Jiménez E, Titos MJ .Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer. Breast Cancer Research 2007, 9(Suppl 1):P111465-5411http://hdl.handle.net/10668/556Poster Presentation. This article is part of the supplement: VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer.Trastuzumab and gemcitabine are two active drugs for meta-static breast cancer (MBC) treatment. We conducted a retrospective study of this combination in patients with Her2+ MBC in our hospital.enAnticuerpos Monoclonales HumanizadosAntineoplásicosNeoplasias de la MamaMetástasis de la NeoplasiaAntimetabolitos AntineoplásicosFemeninoHumanosReceptor erbB-2Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, HumanizedMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic AgentsMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast NeoplasmsMedical Subject Headings::Diseases::Neoplasms::Neoplastic Processes::Neoplasm MetastasisMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, AntineoplasticMedical Subject Headings::Check Tags::FemaleMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::HumansMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2conference posteropen access10.1186/bcr17171465-542X